Skip to main content

Advertisement

SpringerLink
Log in

Minimal hepatic encephalopathy

  • Review
  • Published:
Indian Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Minimal hepatic encephalopathy (MHE) is the mildest form of spectrum of hepatic encephalopathy (HE). Patients with MHE have no recognizable clinical symptoms of HE but have mild cognitive and psychomotor deficits. The prevalence of MHE is high in patients with cirrhosis of liver and varies between 30% and 84%; it is higher in patients with poor liver function. The diagnostic criteria for MHE have not been standardized but rest on careful patient history and physical examination, normal mental status examination, demonstration of abnormalities in cognition and/or neurophysiological function, and exclusion of concomitant neurological disorders. MHE is associated with impaired health-related quality of life, predicts the development of overt HE and is associated with poor survival. Hence, screening all patients with cirrhosis for MHE using psychometric tests, and treatment of those patients diagnosed to have MHE has been recommended. Ammonia plays a key role in the pathogenesis of MHE, which is thought to be similar to that of overt HE. Thus, ammonia-lowering agents such as lactulose and probiotics have been tried. These agents have been shown to improve cognitive and psychometric deficits, and have good safety profile. Future studies will better define the role of other drugs, such as rifaximin, acetyl L-carnitine and L-ornithine L-aspartate.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Singapore)

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy — definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002;35:716–721.

    Article  PubMed  Google Scholar 

  2. Mullen KD. Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy. Aliment Pharmacol Ther 2007;25Suppl 1:11–16.

    PubMed  Google Scholar 

  3. Kharbanda PS, Saraswat VA, Dhiman RK: minimal hepatic encephalopathy: diagnosis by neurophchological and neurophysiological methods. Indian J Gastroenterol 2003;22(Suppl 2):537–541.

    Google Scholar 

  4. Ortiz M, Jacas C, Cordoba J. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. J Hepatol 2005;42(Suppl 1):S45–S53.

    Article  PubMed  Google Scholar 

  5. Rikkers L, Jenko P, Rudman D, Freides D. Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism. Gastroenterology 1978;75:462–469.

    PubMed  CAS  Google Scholar 

  6. Schomerus H, Hamster W, Blunck H, Reinhard U, Mayer K, Doell W. Latent portasystemic encephalopathy. I. Nature of cerebral function defects and their effect on fitness to drive. Dig Dis Sci 1981;26:622–630.

    Article  PubMed  CAS  Google Scholar 

  7. Zeegen R, Drinkwater JE, Dawson AM. Method for measuring cerebral dysfunction in patients with liver disease. Br Med J 1970;2:633–636.

    Article  PubMed  CAS  Google Scholar 

  8. Rikkers L, Jenko P, Rudman D, Freides D. Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism. Gastroenterology 1978;75:462–469.

    PubMed  CAS  Google Scholar 

  9. Amodio P, Del Piccolo F, Petteno E, et al. Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients. J Hepatol 2001;35:37–45.

    Article  PubMed  CAS  Google Scholar 

  10. Nolte W, Wiltfang J, Schindler C, et al. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations. Hepatology 1998;28:1215–1225

    Article  PubMed  CAS  Google Scholar 

  11. Boyer TD, Haskal ZJ, American Association for the Study of Liver Diseases. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology 2005;41:386–400.

    Article  PubMed  Google Scholar 

  12. Quero JC, Schalm SW. Subclinical hepatic encephalopathy. Semin Liver Dis 1996;16:321–328.

    Article  PubMed  CAS  Google Scholar 

  13. Romero-Gomez M, Boza F, Garcia-Valdecasas MS, García E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 2001;96:2718–2723.

    PubMed  CAS  Google Scholar 

  14. Das A, Dhiman RK, Saraswat VA, Naik SR. Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis. J Gastroenterol Hepatol 2001;16:531–535.

    Article  PubMed  CAS  Google Scholar 

  15. Hartmann IJ, Groeneweg M, Quero JC, et al. The prognostic significance of subclinical hepatic encephalopathy. Am J Gastroenterol 2000;95:2029–2034.

    Article  PubMed  CAS  Google Scholar 

  16. Kircheis G, Wettstein M, Timmermann L, Schnitzler A, Häussinger D. Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology 2002;35:357–366.

    Article  PubMed  Google Scholar 

  17. Groeneweg M, Quero JC, De Bruijn I, et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998;28:45–49.

    Article  PubMed  CAS  Google Scholar 

  18. Groeneweg M, Moerland W, Quero JC, Hop WCJ, Krabbe P, Schalm SW. Screening of subclinical hepatic encephalopathy. J Hepatol 2000;32:748–753.

    Article  PubMed  CAS  Google Scholar 

  19. Quero JC, Hartmann IJC, Meulstee J, Hop WCJ, Schalm SW. The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropshychological tests and automated electroencephalogram analysis. Hepatology 1996;24:556–560.

    Article  PubMed  CAS  Google Scholar 

  20. Kurmi R, Reddy K, Dhiman RK, et al. Psychometric hepatic encephalopathy score, critical flicker frequency and p300 event-related potential for the diagnosis of minimal hepatic encephalopathy: Evidence that psychometric hepatic encephalopathy score is enough. Indian J Gastroenterol 2008;27(Suppl 1):S1.

    Google Scholar 

  21. Sarin SK, Nundy S. Subclinical encephalopathy after portosystemic shunts in patients with non-cirrhotic portal fibrosis. Liver 1985;5:142–146.

    PubMed  CAS  Google Scholar 

  22. Mínguez B, García-Pagán JC, Bosch J, et al. Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy. Hepatology 2006;43:707–714.

    Article  PubMed  Google Scholar 

  23. Sharma P, Sharma BC, Puri V, Sarin SK. Minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction. Am J Gastroenterol 2008;103:1406–1412.

    Article  PubMed  Google Scholar 

  24. Sharma P, Sharma BC, Tyagi P, Kumar M, Sarin SK. Neuropsychological impairment in severe acute viral hepatitis is due to minimal hepatic encephalopathy. Liver Int 2008;29:260–264.

    PubMed  Google Scholar 

  25. Perry W, Hilsabeck RC, Hassanein TI. Cognitive dysfunction in chronic hepatitis C: a review. Dig Dis Sci 2008;53:307–321.

    Article  PubMed  Google Scholar 

  26. Citro V, Milan G, Tripodi FS, Gennari A, Sorrentino P, Gallotta G, et al. Mental status impairment in patients with West Haven grade zero hepatic encephalopathy: the role of HCV infection. J Gastroenterol 2007;42:79–82.

    Article  PubMed  Google Scholar 

  27. Weissenborn K, Krause J, Bokemeyer M, et al. Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy. J Hepatol 2004;41:845–885.

    Article  PubMed  Google Scholar 

  28. Hilsabeck RC, Hassanein TI, Carlson MD, Ziegler EA, Perry W. Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C. J Int Neuropsychol Soc 2003;9:847–854.

    Article  PubMed  Google Scholar 

  29. Hilsabeck RC, Hassanein TI, Ziegler EA, Carlson MD, Perry W. Effect of interferon-alpha on cognitive functioning in patients with chronic hepatitis C. J Int Neuropsychol Soc 2005;11:16–22.

    Article  PubMed  CAS  Google Scholar 

  30. Fontana RJ, Bieliauskas LA, Lindsay KL, et al. Cognitive function does not worsen during pegylated interferon and ribavirin retreatment of chronic hepatitis C. Hepatology 2007;45:1154–1163.

    Article  PubMed  CAS  Google Scholar 

  31. Butterworth RF. Pathophysiology of hepatic encephalopathy: a new look at ammonia. Metab Brain Dis 2002;17:221–227

    Article  PubMed  CAS  Google Scholar 

  32. Vaquero J, Chung C, Blei AT. Brain edema in acute liver failure. A window to the pathogenesis of hepatic encephalopathy. Ann Hepatol 2003;2:12–22.

    PubMed  Google Scholar 

  33. Takano T, Tian GF, Peng W, et al. Astrocyte-mediated control of cerebral blood flow. Nat Neurosci 2006;9:260–270.

    Article  PubMed  CAS  Google Scholar 

  34. Ahboucha S, Butterworth RF. The neurosteroid system: implication in the pathophysiology of hepatic encephalopathy. Neurochem Int 2008;52:575–587.

    Article  PubMed  CAS  Google Scholar 

  35. Balata S, Damink SW, Ferguson K, et al. Induced hyperammonemia alters neuropsychology, brain MR spectroscopy and magnetization transfer in cirrhosis. Hepatology 2003;37:931–939.

    Article  PubMed  CAS  Google Scholar 

  36. Cordoba J, Alonso J, Rovira A, et al. The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation. J Hepatol 2001;35:598–604.

    Article  PubMed  CAS  Google Scholar 

  37. Lockwood AH, Yap EW, Wong WH. Cerebral ammonia metabolism in patients with severe liver disease and minimal HE. J Cereb Blood Flow Metab 1991;11:337–341.

    PubMed  CAS  Google Scholar 

  38. Kale RA, Gupta RK, Saraswat VA, et al. Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy. Hepatology 2006;43:698–706.

    Article  PubMed  Google Scholar 

  39. Shawcross DL, Davies NA, Williams R, Jalan R. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol 2004;40:247–254.

    Article  PubMed  CAS  Google Scholar 

  40. Shawcross DL, Wright G, Olde Damink SW, Jalan R. Role of ammonia and inflammation in minimal hepatic encephalopathy. Metab Brain Dis 2007;22:125–138.

    Article  PubMed  CAS  Google Scholar 

  41. Das K, Singh P, Chawla Y, Duseja A, Dhiman RK, Suri S. Magnetic resonance imaging of brain in patients with cirrhotic and non-cirrhotic portal hypertension. Dig Dis Sci 2008;53:2793–2798.

    Article  PubMed  Google Scholar 

  42. Rama Rao KV, Reddy PV, Hazell AS, Norenberg MD. Manganese induces cell swelling in cultured astrocytes. Neurotoxicology 2007;28:807–812.

    Article  PubMed  CAS  Google Scholar 

  43. Ortiz M, Cordoba J, Doval E, Jacas C, Pujadas F, Esteban R, Guardia J. Development of a clinical hepatic encephalopathy staging scale. Aliment Pharmacol Ther 2007;26:859–867.

    Article  PubMed  CAS  Google Scholar 

  44. Amodio P, Montagnese S, Gatta A, Morgan MY. Characteristics of minimal hepatic encephalopathy. Metab Brain Dis 2004;19:253–267.

    Article  PubMed  Google Scholar 

  45. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.

    Article  PubMed  CAS  Google Scholar 

  46. Venktaramarao SH, Mittal, Prabhakar S, Dhiman RK. Brain perfusion single photon emission computed tomography (SPECT) abnormalities in patients with minimal hepatic encephalopathy (abstract). J Gastroenterol Hepatol 2008;23(Suppl 5):A62.

    Google Scholar 

  47. Grover VP, Dresner MA, Forton DM, et al. Current and future applications of magnetic resonance imaging and spectroscopy of the brain in hepatic encephalopathy. World J Gastroenterol 2006;12:2969–2978.

    PubMed  CAS  Google Scholar 

  48. Weissenborn K, Ennen JC, Schomerus H, Rückert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001;34:768–773.

    Article  PubMed  CAS  Google Scholar 

  49. Romero-Gómez M, Córdoba J, Jover R, et al. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology 2007;45:879–885.

    Article  PubMed  Google Scholar 

  50. Dhiman RK, Saraswat VA, Verma M, Naik SR. Figure connection test: A modified number connection test for the objective assessment of mental state in illiterates. J Gastroenterol Hepatol 1995;10:14–23.

    Article  PubMed  CAS  Google Scholar 

  51. Weissenborn K. PHES: one label, different goods?! J Hepatol 2008;49:308–312.

    Article  PubMed  Google Scholar 

  52. Mardini H, Saxby BK, Record CO. Computerized psychometric testing in minimal encephalopathy and modulation by nitrogen challenge and liver transplant. Gastroenterology 2008;135:1582–1590.

    Article  PubMed  Google Scholar 

  53. Wesnes KA, Ward T, McGinty A, Petrini O. The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers. Psychopharmacology 2000;152:353–361.

    Article  PubMed  CAS  Google Scholar 

  54. Forton DM, Thomas HC, Murphy CA, et al. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 2002;35:433–439.

    Article  PubMed  Google Scholar 

  55. Sharma P, Sharma BC, Puri V, Sarin SK. Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy. J Hepatol 2007;47:67–73.

    Article  PubMed  CAS  Google Scholar 

  56. Bajaj JS, Hafeezullah M, Franco J, et al. Inhibitory control test for the diagnosis of minimal hepatic encephalopathy. Gastroenterology 2008;135:1591–1600.

    Article  PubMed  Google Scholar 

  57. Montoliu C, Piedrafita B, Serra MA, et al. IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy. J Clin Gastroenterol 2008 Jun 16. [Epub ahead of print].

  58. Groeneweg M, Quero JC, De Bruijn I, et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998;28:45–49.

    Article  PubMed  CAS  Google Scholar 

  59. Prasad S, Dhiman RK, Duseja A, Chawla Y, Sharma A, Agarwal R. Lactulose improves cognitive functions and health-related quality of life in cirrhotic patients with minimal hepatic encephalopathy. Hepatology 2007;45:549–559.

    Article  PubMed  Google Scholar 

  60. Schomerus H, Hamster W. Quality of life in cirrhotics with minimal hepatic encephalopathy. Metab Brain Dis 2001;16:37–41.

    Article  PubMed  CAS  Google Scholar 

  61. Bao ZJ, Qiu DK, Ma X, et al. Assessment of health-related quality of life in Chinese patients with minimal hepatic encephalopathy. World J Gastroenterol 2007;13:3003–3008.

    PubMed  Google Scholar 

  62. Arguedas MR, DeLawrence TG, McGuire BM. Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis. Dig Dis Sci 2003;48:1622–1626.

    Article  PubMed  Google Scholar 

  63. Cordoba J, Cabrera J, Lataif L, Pener P, Zee P, Blei AT. High prevalence of sleep disturbances in cirrhosis. Hepatology 1998;27:339–345.

    Article  PubMed  CAS  Google Scholar 

  64. Weissenborn K, Heidenreich S, Giewekemeyer K, Ruckert N, Hecker H. Memory function in early hepatic encephalopathy. J Hepatol 2003;39:320–325.

    Article  PubMed  Google Scholar 

  65. Schomerus H, Hamster W, Blunck H, Reinhard U, Mayer K, Dolle W. Latent portasystemic encephalopathy. I. Nature of cerebral functional defects and their effect on fitness to drive. Dig Dis Sci 1981;26:622–630.

    Article  PubMed  CAS  Google Scholar 

  66. Watanabe A, Tuchida T, Yata Y, Kuwabara Y. Evaluation of neuropsychological function in patients with liver cirrhosis with special reference to their driving ability. Metab Brain Dis 1995;10:239–248.

    Article  PubMed  CAS  Google Scholar 

  67. Srivastava A, Mehta R, Rothke SP, Rademaker AW, Blei AT. Fitness to drive in patients with cirrhosis and portal-systemic shunting: a pilot study evaluating driving performance. J Hepatol 1994;21:1023–1028.

    Article  PubMed  CAS  Google Scholar 

  68. Wein C, Koch H, Popp B, Oehler G, Schauder P. Minimal hepatic encephalopathy impairs fitness to drive. Hepatology 2004;39:739–745.

    Article  PubMed  Google Scholar 

  69. Marotolli RA, Cooney LM, Wagner S, Doucette J, Tinetti ME. Predictors of automobile crashes and moving violations among elderly drivers. Ann Intern Med 1994;121:842–846.

    Google Scholar 

  70. Bajaj JS, Hafeezullah M, Hoffmann RG, Saeian K. Minimal hepatic encephalopathy: a vehicle for accidents and traffic violations. Am J Gastroenterol 2007;102:1903–1909.

    Article  PubMed  Google Scholar 

  71. Bajaj JS, Hafeezullah M, Hoffmann RG, et al. Navigation skill impairment: another dimension of the driving difficulties in minimal hepatic encephalopathy. Hepatology 2008;47:596–604.

    Article  PubMed  Google Scholar 

  72. Romero-Gomez M, Boza F, Garcia-Valdecasas MS, Garcia E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 2001;96:2718–2723.

    PubMed  CAS  Google Scholar 

  73. Amodio P, Del Piccolo F, Marchetti P, et al. Clinical features and survival of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests. Hepatology 1999;29:1662–1667.

    Article  PubMed  CAS  Google Scholar 

  74. Saxena N, Bhatia M, Joshi YK, Garg PK, Tandon RK. Auditory P300 event-related potentials and number connection test for evaluation of subclinical hepatic encephalopathy in patients with cirrhosis of the liver: a follow-up study. J Gastroenterol Hepatol 2001;16:322–327.

    Article  PubMed  CAS  Google Scholar 

  75. Saxena N, Bhatia M, Joshi YK, Garg PK, Dwivedi SN, Tandon RK. Electrophysiological and neuropsychological tests for the diagnosis of subclinical hepatic encephalopathy and prediction of overt encephalopathy. Liver 2002;22:190–197.

    Article  PubMed  Google Scholar 

  76. Yen CL, Liaw YF. Somatosensory evoked potentials and number connection test in the detection of hepatic encephalopathy. Hepatogastroenterology 1990;37:332–334.

    PubMed  CAS  Google Scholar 

  77. Romero-Gomez M, Grande L, Camacho I, Benitez S, Irles JA, Castro M. Altered response to oral glutamine challenge as prognostic factor for overt episodes in patients with minimal hepatic encephalopathy. J Hepatol 2002;37:781–787.

    Article  PubMed  CAS  Google Scholar 

  78. Romero-Gomez M, Grande L, Camacho I. Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy. Hepatology 2004;39:939–943.

    Article  PubMed  Google Scholar 

  79. Dhiman RK, Solanki KK. Management of hepatic encephalopathy: Seen and Unseen. In: Medicine Update Vol 17; Ed YK Munjal. 2007; pp 259–271.

  80. de Bruijn KM, Blendis LM, Zilm DH, Carlen PL, Anderson GH. Effect of dietary protein manipulation in subclinical portal-systemic encephalopathy. Gut 1983;24:53–60.

    Article  PubMed  Google Scholar 

  81. Egberts EH, Schomerus H, Hamster W, Jurgens P. Branched chain amino acids in the treatment of latent portosystemic encephalopathy. A double-blind placebo-controlled crossover study. Gastroenterology 1985;88:887–895.

    PubMed  CAS  Google Scholar 

  82. Plauth M, Egberts EH, Hamster W, et al. Longterm treatment of latent portosystemic encephalopathy with branched-chain amino acids: a double blind placebo-controlled cross over study. J Hepatol 1993:17;308–314.

    Article  PubMed  CAS  Google Scholar 

  83. McClain CJ, Potter TJ, Kromhort JP, Zieve L. The effect of lactulose on psychomotor performance tests in alcoholic cirrhosis without over HE. J Clin Gastroenterol 1981;6:325–329.

    Google Scholar 

  84. Morgan MY, Alonso M, Stanger LC. Lactilol and lactulose for treatment of subclinical HE in cirrhotic patients. J Hepatol 1989;8:208–217.

    Article  PubMed  CAS  Google Scholar 

  85. Watanable A, Sakai T, Sato S, et al. Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy. Hepatology 1997;26:1410–1414.

    Article  Google Scholar 

  86. Horsmans Y. Solbreux PM, Daenens C. Desager JP, Geubel AP. Lactulose improves psychometric testing in cirrhotic patients with subclinical encephalpathy. Aliment Pharmacol Ther 1997:11:165–170.

    Article  PubMed  CAS  Google Scholar 

  87. Quero JC, Groenweg M, Muelster J, Hop WCJ, Schalm SW. Does a low dose of lactulose improve quality of life in patients with liver cirrhosis. In: Record C, Al Mardini H, eds. Advances in Hepatic Encephalopathy & Metabolism in Liver Disease. New Castle Upon Tyne: Medical faculty, University of Newcastle upon Tyne; 1997; p. 459–465.

    Google Scholar 

  88. Li Z, Zhang H, Hong Y. Clinical effect of lactulose in the treatment of subclinical hepatic encephalopathy. Zhongguo Zhong Xi Yi Jie He Za Zhi 1999;9:13–15.

    CAS  Google Scholar 

  89. Dhiman RK, Sawhney MS, Chawla YK, Das G, Ram S, Dilawari JB. Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy. Dig Dis Sci 2000;45:1549–1552.

    Article  PubMed  CAS  Google Scholar 

  90. Yu-qiang N, Zheng Z, Yu-yuan L, Wei-hong S, Li P, Shou-jun D. Long-term efficacy of lactulose in patients with subclinical hepatic encephalopathy. Chin J Intern Med 2003;42:261–266.

    Google Scholar 

  91. Kale RA, Gupta RK, Saraswat VA, et al. Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy. Hepatology 2006;43:698–706.

    Article  PubMed  Google Scholar 

  92. Amodio P, Marechtti P, Del Piccolo F, et al. The effect of flumazenil on subclinical psychometric or neurophysiological alterations in cirrhotic patients: a double blind placebo controlled study. Clin Physiol 1997;17:533–539.

    Article  PubMed  CAS  Google Scholar 

  93. Kircheis G, Nilius R, Held C, et al. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study. Hepatology 1997;25:1351–1360.

    Article  PubMed  CAS  Google Scholar 

  94. Malaguarnera M, Gargante MP, Cristaldi E, et al. Acetyl-L-carnitine treatment in minimal hepatic encephalopathy. Dig Dis Sci 2008;53:3018–3025.

    Article  PubMed  CAS  Google Scholar 

  95. Liu Q, Duon ZP, Ha DK, Bengmark S, Kurtovic J, Riordan SM. Symbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 2004;39:1441–1449.

    Article  PubMed  Google Scholar 

  96. Bajaj JS, Saeian K, Christensen KM, et al. Probiotic yogurt for the treatment of minimal hepatic encephalopathy. Am J Gastroenterol 2008;103:1707–1715.

    Article  PubMed  Google Scholar 

  97. Malaguarnera M, Greco F, Barone G, Gargante MP, Malaguarnera M, Toscano MA. Bifidobacterium long-um with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study. Dig Dis Sci 2007;52:3259–3265.

    Article  PubMed  Google Scholar 

  98. Sharma P, Sharma BC, Puri V, Sarin SK. An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy. Eur J Gastroenterol Hepatol 2008;20:506–511.

    Article  PubMed  CAS  Google Scholar 

  99. Dhiman RK, Chawla YK. Minimal hepatic encephalopathy: should we start treating it? Gastroenterology 2004;127:1855–1857.

    Article  PubMed  Google Scholar 

  100. Dhiman RK, Chawla YK. Minimal hepatic encephalopathy: Time to recognise and treat. Trop Gastroenterol 2008;29:6–12.

    PubMed  Google Scholar 

  101. Mullen KD, Ferenci P, Bass NM, Leevy CB, Keeffe EB. An algorithm for the management of hepatic encephalopathy. Semin Liver Dis 2007;27(suppl 2):32–47.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160 012, India

    Radha K. Dhiman & Yogesh K. Chawla

Authors
  1. Radha K. Dhiman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yogesh K. Chawla
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Radha K. Dhiman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dhiman, R.K., Chawla, Y.K. Minimal hepatic encephalopathy. Indian J Gastroenterol 28, 5–16 (2009). https://doi.org/10.1007/s12664-009-0003-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12664-009-0003-6

Keywords

Search

Navigation